Gene · 4591
NIH grants974
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 974
Download this page as JSON| Grant | Title | TRIM37 papers | Newest fiscal year |
|---|---|---|---|
| K23AI137183 | Role of B cell activating factor in non-infectious complications of common variable immunodeficiency | 2 | 2022 |
| R01MH116695 | Towards Suppression and Elimination of HIV in the CNS | 2 | 2022 |
| K01DA046307 | Quantifying health policy impacts on substance use and treatment among women with and at risk for HIV: a longitudinal multilevel analysis using the Women's Interagency HIV Study | 1 | 2022 |
| K08DK118120 | Hypoxic preconditioning for the improvement of the regenerative capacity of adipose-derived mesenchymal stem cells and its application in chronic kidney disease due to hypertensive nephropathy | 1 | 2022 |
| P01CA148600 | Novel Cord Blood-Derived Cellular Therapies | 1 | 2022 |
| P01HL108793 | Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD) | 1 | 2022 |
| P30ES006096 | Center for Environmental Genetics | 1 | 2022 |
| P50CA140388 | Administrative Supplement to MD Anderson Cancer Center Prostate Cancer SPORE | 1 | 2022 |
| P50CA150964 | Case GI SPORE | 1 | 2022 |
| R00AI147811 | The Vif-APOBEC Nexus | 1 | 2022 |
| R01AI139633 | Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1 | 1 | 2022 |
| R01AR072027 | Developing Nanomaterial Platform for Intra-Cartilage Delivery of RNA Therapeutics against Joint Diseases | 1 | 2022 |
| R01CA172845 | Metabolic Reprogramming in Brain Tumors | 1 | 2022 |
| R01CA222560 | Interplay of mammary luminal cells and environmental factors in establishing p53-deficient premalignant field | 1 | 2022 |
| R01CA227918 | Role of NF90 in Prostate Cancer | 1 | 2022 |
| R01CA229777 | Clinical platform for high-throughput analyses of extracellular vesicles | 1 | 2022 |
| R01DE026806 | Protease/PAR2/TRPV4 Axis and Oral Cancer Pain | 1 | 2022 |
| R01DK068306 | Novel genetics, pathobiology and therapy of nephronophthisis-related ciliopathies | 1 | 2022 |
| R01ES028277 | Developmental neurotoxicity of organophosphate and novel brominated flame retardants in children | 1 | 2022 |
| R01ES029212 | Placental Functional Networks Linking Developmental Pesticide Exposure and Offspring Neurodevelopment | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4591/grants?page=17